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Introduction
PPARγ (Peroxisome proliferator-activated receptor γ ) coactivator-1 alpha (PGC-1α) is a master regulator of cellular energy homeostasis and plays important roles in adaptive thermogenesis in skeletal muscle and brown fat, mitochondrial biogenesis and respiration in muscle cells, and in liver gluconeogenesis. PGC-1α expression is highly induced in liver and heart during fasting period, in brown adipose tissue following the exposure to cold temperature, and in skeletal muscle while exercising (Finck and Kelly, 2006; Lin et al., 2005) . PGC-1α can co-activate a variety of transcription factors including but not limited to all ERR and PPAR subtypes, nuclear respiratory factor (NRF1), forkhead box O1 (FOXO1) and hepatocyte nuclear factor 4 (HNF4) (Lin et al., 2005) . The PGC-1α knockout mice exhibit multiple metabolic defects, indicating its involvement in numerous pathogenic conditions such as obesity, diabetes, neuro-degeneration and cardio-myopathy (Leone et al., 2005; Lin et al., 2004) .
Estrogen-related receptors (ERR) belong to a family of orphan nuclear hormone receptors consisting of ERRα, ERRβ and ERRγ. ERRα participates in the metabolic regulation, and is expressed in various tissues. Its expression is elevated in tissues with increased metabolic demands such as the heart, kidney, skeletal muscle and adipose tissue (Horard and Vanacker, 2003; Tremblay and Giguere, 2007) . ERRα-ablated mice are resistant to obesity that is induced by a high-fat diet, and exhibit reduced lipogenesis in their adipose tissue (Luo et al., 2003) .
ERRα-regulated genes include pyruvate dehydrogenase kinase 4 (PDK4), a key enzyme of glucose metabolism, and medium chain acyl-CoA dehydrogenase (MCAD), a rate-limiting enzyme catalyzing the mitochondrial beta-oxidation of fatty acids . In addition to co-activating ERRα, PGC-1α can also strongly induce ERRα mRNA expression, which in turn stimulates its own expression, thereby generating a positive feedback loop (Laganiere et al., 2004; Mootha et al., 2004) . ERRα has also been shown to be associated with This article has not been copyedited and formatted. The final version may differ from this version. osteoporosis, metabolic disorders and cancers. For example, ERRα contributes to the breast cancer and progression of ovarian malignancies, and serves as a potential therapeutic target (Stein and McDonnell, 2006) .
Uridine phosphorylase (UPase) catalyzing the formation of uracil from uridine participates in the regulation of pyrimidine salvage pathway and activates fluoropyrimidines, for example, 5'-deoxy-5-fluorouridine (5'-DFUR) (Cao et al., 2005; Cao et al., 2002) . UPase activity is amplified in many tumors including colorectal carcinomas, breast cancer, melanoma and lung adenocarcinomas, suggesting that this enzyme is an important target for tumor-specific modulation of fluoropyrimidines reactivity (Wan et al., 2006) . 5-FU is one of the active antitumor agents used in treatment of multiple tumors. Capecitabine is an oral agent that is designed to generate 5-FU preferentially in the tumor tissues. 5'-DFUR, an intermediate metabolite of capecitabine, is converted to 5-FU by two pyrimidine phosphorylases, UPase and thymidine phosphorylase (TPase), both of which are elevated in tumor tissues Wan et al., 2006) .
It has been demonstrated that tumor necrosis factor alpha (TNFα) induces UPase expression through NF-κB pathway and enhances the cell sensitivity to 5'-DFUR (Wan et al., 2006) .
Together with interleukin-1α and interferon-γ, TNFα accentuates the tumor cytotoxicity of 5-FU and 5'-DFUR by 2.7 and 12.4-fold, respectively. In contrast, p53 decreases UPase expression by physically interacting with its promoter region. (Zhang et al., 2001) . EWS/ETS fusion proteins, playing a dominant oncogenic role in cellular transformation, can stimulate UPase gene expression through interaction with the UPase promoter. In addition, the upregulation of UPase by EWS/FLI 1 sensitizes cells to in vitro growth inhibition by 5'-DFUR (Deneen et al., 2003) .
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Materials and Methods
Plasmids and Adenoviral Vectors
The mouse UPase gene promoter (-1108 bp to +143 bp) was amplified as described previously (Cao et al., 1999) primers and pcDNA3.1-ERRα template. Recombination with pAdEasy-1 and propagation of adenovirus expressing PGC-1α and ERRα in the 293A cell line was performed as described elsewhere (He et al., 1998) .
This article has not been copyedited and formatted. The final version may differ from this version. were cultured in RPMI-1640 and IMDM, respectively (10% FBS, 37°C, 5% CO 2 ). The cells were infected at a multiplicity of infection sufficient to infect >95% of cells as determined by GFP fluorescence.
Enzymatic Activity Assay
UPase activity (uridine conversion to uracil) was determined by TLC chromatographic separation as described previously (Liu et al., 1998; Zhang et al., 2001 ). Briefly, cell lysates were prepared in 50 mM Tris-Cl (pH 7.5), and supernatant (20,000g, 1 hr, 4°C) was used to estimate the UPase activity. The enzyme reaction was carried out in a total volume of 100 μ l of 50 mM
Tris-Cl buffer (pH 7.5) containing 1 mM potassium phosphate and 200 μ M [5-the radioactivity was measured by Beckman scintillation counter. Protein concentrations were determined by the BCA method (Pierce).
Electrophoretic Mobility Shift Assay (EMSA)
LightShift Chemiluminescent EMSA Kit (Pierce) was used according to the manufacturer's instructions. Briefly, 293A cells were seeded in 100 mm dish followed by transfection with ERRexpressing plasmid (10 μ g). After 24h, the nuclear proteins were extracted according to the protocol (Pierce). The sequence of UPase-ERRE-wt (wild-type) oligonucleotide was 5'-CCTGGCCTCTGTCCTTGGGTGACCTTAGCCGAG-3'; whereas the sequence of the UPase-ERRE-mutant was 5'-CCTGGCCTCTGTCCTTGGGTGAttTTAGCCGAG-3'. Equal amounts of complementary oligonucleotides were annealed and labeled by 5'-end labeling with biotin.
The binding reactions were executed in a total volume of 20 μ l containing 50 mM KCl, 5 mM MgCl 2, 10 mM EDTA, 5% glycerol, 3 μ l of nuclear extract, 1 μ g of poly (dI-dC) and 2 μ l binding buffer. To perform the competition analysis, 200-fold molar excess of unlabeled competitor DNA was added to the reaction prior to the addition of the nuclear extracts. After pre-incubation for 10 min at room temperature, 20 fmol of biotin-labeled probe was added, and the incubation was continued for an additional 20 min. The electrophoresis was done with a 6% polyacrylamide gel in 0.5x TBE buffer at 100 V. The samples were blotted onto a nylon membrane using an electrophoretic transfer unit (380 mA, 60 min). Subsequently, the DNA was cross-linked to membrane (120 mJ/cm 2 , 60 sec) and the biotin-labeled DNA was detected by chemiluminescence reagent.
Growth Inhibition Assays and FACS Analysis
The anti-proliferative activity of 5'-DFUR (Sigma) was assessed by means of the 'CellTiter 96' proliferation assay. Briefly, 5x10 3 cells were seeded in 96-well plates and allowed to adhere for This article has not been copyedited and formatted. The final version may differ from this version. ethanol at 4°C for at least 8 hrs. Then, the fixed cells were collected by brief centrifugation and resuspended in PBS containing 100 μ g/ml of RNase A and 50 μ g/ml of propidium iodide.
Following 30 min incubation at room temperature, samples were analyzed by flow cytometric analysis for the presence of apoptotic cells (subG1) according to their DNA content.
Quantitative PCR
Total RNA was extracted by TRIzol-based method and subjected to the cDNA synthesis using random hexamers and reverse transcription reagent kit (Invitrogen). The forward and reverse primers, 5'-GGCAGAGTTTGAGCAGATTGT-3' and 5'-CAGATACGCCTGCTTGTCCTT-3', were used to measure the UPase transcript. The mRNA of β -actin was employed as an internal control using 5'-AGCGGGAAATCGTGCGTGAC-3' and 5'-CGGACTCGTCATACTCCTGCT-3' primers. The real-time PCR was performed with SYBR Green PCR mastermix (Invitrogen) on a Bio-Rad IQ5 system.
Statistical Analysis
The data presented in this research are reported as the mean ± SD of at least three independent experiments. Differences between groups were compared by Student's t test, and P values﹤0.05
were considered to be statistically significant.
This article has not been copyedited and formatted. The final version may differ from this version. of the promoter region from -1108 to -924 bp (Fig. 2) .
To deduce the molecular mechanism, we searched for the sequence motif in the PGC-1α-responsive nucleotide region. A screen of 185 bp between -1108 and -924 bp revealed the presence of a putative ERRE (TGACCTTAG, -1078 to -1070 bp). The fact that PGC-1α can induce ERRα expression and coactivate ERR subtypes (Laganiere et al., 2004; Mootha et al., 2004) prompted us to speculate the participation of ERRs in PGC-1α-induced activation of UPase. Interestingly, further truncation of the promoter between -924 and -413 bp did not accentuate the process. We also observed that PGC-1α was still competent in stimulating the UPase promoter (UPase.Luc-924 and UPase.Luc-413) when compared to the empty vector (pcDNA3.1), which implicates that factors other than ERR also contributes to the observed residual transcriptional activation by PGC-1α.
PGC-1α-dependent activation of UPase promoter is mediated by ERR
Mutational studies were performed to examine the participation of ERR subtypes in the PGC-1α-dependent activation of the UPase promoter. The potential ERRE (TGACCTTAG, -1078 to1070bp) within the UPase promoter was abolished using a mutation that has been shown previously to inactivate this element . As shown in Fig. 3A , cotransfection of a PGC-1α expression vector with UPase.Luc-1108 resulted in about 7-fold induction of UPase promoter. However, PGC-1α-mediated transcription through UPase promoter is considerably reduced with ERRE mutant (Fig. 3A) suggesting the involvement of ERRs in PGC-1α action.
Notably, we again observed the modest activation of mutant UPase promoter, which further confirmed the participation of other factors in the mentioned function of PGC-1α.
To determine if ERR protein binds to the PGC-1α-responsive element identified within the UPase promoter, the EMSA were performed using the nuclear extracts and the synthetic doubleThis article has not been copyedited and formatted. The final version may differ from this version. 
PGC-1α-dependent induction of UPase gene in cancer cells is mediated by ERRα
To resolve the function of ERRα in mediating the induction of UPase transcription by PGC-1α, we carried out adenovirus-mediated individual or collective over-expression of PGC-1α and/or ERRα (Ad-PGC-1α, Ad-ERRα) in MCF-7 cells. As anticipated, we detected about 6-fold induction of UPase mRNA by PGC-1α, while ERRα increased it by a modest 2.5-fold. The cotransfection of both PGC-1α and ERRα resulted in about13-fold induction of UPase transcript (data not shown).
Furthermore, we treated plasmid-recipient cells with XCT790, which is a potent and selective ERRα antagonist and interferes with PGC-1α/ERRα-dependent signaling .
We observed a significant reduction in PGC-1α induction of UPase transcription upon treatment of MCF-7 cells with XCT790. Although substantial, the inhibition of ERRα protein by XCT790
did not entirely abolish the action of PGC-1α on the UPase gene (Fig. 4A) . These data were also corroborated in HepG2 cells using luciferase reporter construct where the activity of PGC-1α was significantly decreased but not eliminated (Fig. 4B) . Collectively, our data suggest the active involvement of ERRα, at least in part, in facilitating the function of PGC-1α.
Over-expression of PGC-1α sensitizes cancer cells to 5'-DFUR
UPase is strongly induced in a variety of human tumors and transformed cells that underlines the tumor-specific reactivity of fluoropyrimidines including 5'-DFUR and capecitabine. Based on these data, we reasoned that the over-expression of PGC-1α should sensitize cancer cells to antiproliferative effect of 5'-DFUR. To validate this presumption, cell proliferation assays were performed on breast and colon cancer cell lines. After infection of SK-BR-3 with Ad-PGC-1α, the drug susceptibility of these breast cancer cells to 5'-DFUR was increased by 2.4-fold that corresponds to a reduction in its IC 50 value from 120 to 50 μ M (Fig. 5A) . However, cells infected with Ad-PGC-1α but treated with XCT790 were less susceptible to 5'-DFUR than untreated cells harboring the Ad-PGC-1α (IC 50 value increases from 50 μ M to 100 μ M) (Fig. 5A) . Similar results were obtained with the colon cancer cells, Colo320 (Fig. 5B ). These data underscore the contribution of ERRα in sensitizing the breast and colon cancer cells to 5'-DFUR.
To elucidate if PGC-1α-augmented anti-proliferative activity of 5'-DFUR was due to increased apoptosis of the cancer cells, the apoptotic index was determined by flow cytometry. Indeed, the over-expression of PGC-1α alone stimulated apoptosis rates in breast as well as in the colon cancer cells as determined by the fraction of cells with subG0/G1 DNA content (Fig. 6 ).
Expectedly, co-infection of cancer cells with adenoviruses expressing both PGC-1α and ERRα inflicted a higher susceptibility to 5'-DFUR, and XCT790 reversed the phenomenon (Fig. 6 ).
Taken together, these results confirm that PGC-1α-stimulated anti-proliferative effect of 5'-DFUR is due to an enhanced apoptosis in the recipient cancer cell lines, and the process is mediated by ERRα.
This article has not been copyedited and formatted. The final version may differ from this version. ERRγ are coexpressed in metabolically active tissues including heart, kidney and muscles. The typical ERR binding motif is TCAAGGTCA (Tremblay and Giguere, 2007) , and the nucleotide sequence between -1078 and -1070 bp in UPase promoter region resembles the consensus ERR element. Based on these data, we postulate that PGC-1α-induced expression of UPase is mediated by coactivation of a nuclear receptor ERR. Our results also indicate that PGC-1α retains a modest activity in the absence of ERR binding to its motif suggesting the involvement of regulatory factors other than ERRs in regulating the UPase expression. Because NF-κB, EWS/ETS and p53 can also stimulate or inhibit the UPase promoter activity (Deneen et al., 2003; Wan et al., 2006; Zhang et al., 2001) , the possibility of these factors in mediating the PGC-1α
effect cannot be excluded. Previously, Zhang Y et al have reported that PGC-1α induces This article has not been copyedited and formatted. The final version may differ from this version. apoptosis in the ovarian epithelial cancers; however, the mechanism of its action remains unclear (Zhang et al., 2007) . Hereby, we show that PGC-1α can predispose the colon and breast cancer cells to growth inhibition and apoptosis by 5'-DFUR in an ERR-dependent manner.
PGC-1α is a master regulator of cellular energy metabolism. Its dysregulation is associated with the insulin resistance and mitochondrial dysfunction in type 2 diabetic patients (Andrulionyte et al., 2004; Ek et al., 2001 ). This study underlines the regulatory function of PGC-1α in nucleotide metabolism that is quite discernible as the malignant transformation is often linked to the 
